Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Physiol Gastrointest Liver Physiol ; 281(4): G1081-91, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11557529

ABSTRACT

A poorly defined negative feedback loop decreases transcription of the L-histidine decarboxylase (HDC) gene. To help understand this regulation, we have studied the effect of HDC protein expression on HDC gene transcription in transfected AGS-B cells. Expression of the rat HDC protein inhibited HDC promoter activity in a dose-dependent fashion. The region of the HDC promoter mediating this inhibitory effect corresponded to a previously defined gastrin and extracellular signal-related kinase (ERK)-1 response element. Overexpression of the HDC protein reduced nuclear factor binding in this region. Experiments employing specific histamine receptor agonists indicated that the inhibitory effect was not dependent on histamine production, and studies with the HDC inhibitor alpha-fluoromethylhistidine revealed that inhibition was unrelated to enzyme activity. Instead, an enzymatically inactive region at the amino terminal of the HDC enzyme (residues 1-271) was shown to mediate inhibition. Fluorescent chimeras containing this domain were not targeted to the nucleus, arguing against specific inhibition of the HDC transcription machinery. Instead, we found that overexpression of HDC protein decreased ERK protein levels and ERK activity and that the inhibitory effect of HDC protein could be overcome by overexpression of ERK1. These data suggest a novel feedback-inhibitory role for amino terminal sequences of the HDC protein.


Subject(s)
Histidine Decarboxylase/metabolism , Mitogen-Activated Protein Kinases/metabolism , Transcription, Genetic/physiology , Animals , Cell Line , Gastrins/pharmacology , Genes, Reporter , Histamine Antagonists/pharmacology , Histidine Decarboxylase/genetics , Humans , Immunoblotting , MAP Kinase Signaling System/physiology , Microscopy, Fluorescence , Promoter Regions, Genetic/genetics , Rats , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Response Elements/genetics , Transfection
2.
J Clin Invest ; 106(4): 533-9, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10953028

ABSTRACT

Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene occur in most colorectal cancers and lead to activation of beta-catenin. Whereas several downstream targets of beta-catenin have been identified (c-myc, cyclin D1, PPARdelta), the precise functional significance of many of these targets has not been examined directly using genetic approaches. Previous studies have shown that the gene encoding the hormone gastrin is activated during colon cancer progression and the less-processed forms of gastrin are important colonic trophic factors. We show here that the gastrin gene is a downstream target of the beta-catenin/TCF-4 signaling pathway and that cotransfection of a constitutively active beta-catenin expression construct causes a threefold increase in gastrin promoter activity. APC(min-/+) mice overexpressing one of the alternatively processed forms of gastrin, glycine-extended gastrin, show a significant increase in polyp number. Gastrin-deficient APC(min-/+) mice, conversely, showed a marked decrease in polyp number and a significantly decreased polyp proliferation rate. Activation of gastrin by beta-catenin may therefore represent an early event in colorectal tumorigenesis and may contribute significantly toward neoplastic progression. The identification of gastrin as a functionally relevant downstream target of the beta-catenin signaling pathway provides a new target for therapeutic modalities in the treatment of colorectal cancer.


Subject(s)
Adenomatous Polyposis Coli/etiology , Cytoskeletal Proteins/physiology , Gastrins/physiology , Trans-Activators , Transcription Factors/physiology , Adenomatous Polyposis Coli/genetics , Adenomatous Polyposis Coli/physiopathology , Animals , Base Sequence , Cytoskeletal Proteins/genetics , DNA Primers/genetics , Disease Models, Animal , Female , Gastrins/deficiency , Gastrins/genetics , Gene Expression , Genes, APC , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Mutation , Promoter Regions, Genetic , Signal Transduction , TCF Transcription Factors , Transcription Factor 7-Like 2 Protein , Transcription Factors/genetics , Transfection , beta Catenin
3.
Mol Cell Biol ; 20(13): 4932-47, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10848618

ABSTRACT

Control of enzymatic function by peptide hormones can occur at a number of different levels and can involve diverse pathways that regulate cleavage, intracellular trafficking, and protein degradation. Gastrin is a peptide hormone that binds to the cholecystokinin B-gastrin receptor and regulates the activity of L-histidine decarboxylase (HDC), the enzyme that produces histamine. Here we show that gastrin can increase the steady-state levels of at least six HDC isoforms without affecting HDC mRNA levels. Pulse-chase experiments indicated that HDC isoforms are rapidly degraded and that gastrin-dependent increases are due to enhanced isoform stability. Deletion analysis identified two PEST domains (PEST1 and PEST2) and an intracellular targeting domain (ER2) which regulate HDC protein expression levels. Experiments with PEST domain fusion proteins demonstrated that PEST1 and PEST2 are strong and portable degradation-promoting elements which are positively regulated by both gastrin stimulation and proteasome inhibition. A chimeric protein containing the PEST domain of ornithine decarboxylase was similarly affected, indicating that gastrin can regulate the stability of other PEST domain-containing proteins and does so independently of antizyme/antizyme inhibitor regulation. At the same time, endoplasmic reticulum localization of a fluorescent chimera containing the ER2 domain of HDC was unaltered by gastrin stimulation. We conclude that gastrin stabilization of HDC isoforms is dependent upon two transferable and sequentially unrelated PEST domains that regulate degradation. These experiments revealed a novel regulatory mechanism by which a peptide hormone such as gastrin can disrupt the degradation function of multiple PEST-domain-containing proteins.


Subject(s)
Gastrins/metabolism , Histidine Decarboxylase/genetics , Histidine Decarboxylase/metabolism , 5' Untranslated Regions , Amino Acid Motifs , Animals , COS Cells/drug effects , COS Cells/metabolism , Dopa Decarboxylase/genetics , Dopa Decarboxylase/metabolism , Endoplasmic Reticulum/metabolism , Enzyme Activation , Enzyme Stability , Gastrins/pharmacology , Isoenzymes/metabolism , MAP Kinase Kinase 1 , Male , Mitogen-Activated Protein Kinase Kinases/metabolism , Ornithine Decarboxylase/genetics , Ornithine Decarboxylase/metabolism , Protein Biosynthesis , Protein Kinase C/drug effects , Protein Kinase C/metabolism , Protein Serine-Threonine Kinases/metabolism , RNA, Messenger , Rats , Rats, Sprague-Dawley , Receptors, Cholecystokinin/genetics , Receptors, Cholecystokinin/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transcription, Genetic , Transfection
4.
Endocrinology ; 140(2): 972-8, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9927331

ABSTRACT

The enzyme arylalkylamine N-acetyltransferase (AANAT; EC 2.3.1.87) has been conventionally linked with the biosynthesis of melatonin within the pineal gland and retina. This study establishes that AANAT messenger RNA (mRNA) and functional enzyme occurs within the pars tuberalis (PT) and to a lesser degree within the pars distalis (PD) of the sheep pituitary gland; expression in these tissues is approximately 1/15th (PT) and 1/300th (PD) of that in the ovine pineal gland. AANAT mRNA in the PT appears to be expressed in the same cells as the Mel1a receptor. No evidence was obtained to indicate that either PT or PD cells have the ability to synthesize melatonin, suggesting that this enzyme plays a different functional role in the pituitary. We also found that cAMP regulation of the abundance of AANAT mRNA differs between the PT and pineal gland. Forskolin (10 microM) has no effect on pineal AANAT mRNA levels, yet represses expression in the PT. This suppressive influence could be mediated by ICER (inducible cAMP response early repressor), which is induced by forskolin in both tissues. Although it appears that the specific function and regulation of AANAT in the pituitary gland differ from that in the pineal gland, it seems likely that AANAT may play a role in the broader area of signal transduction through the biotransformation of amines.


Subject(s)
Arylamine N-Acetyltransferase/metabolism , Pineal Gland/enzymology , Pituitary Gland/enzymology , Repressor Proteins , Animals , Arylamine N-Acetyltransferase/genetics , Colforsin/pharmacology , Cyclic AMP/physiology , Cyclic AMP Response Element Modulator , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Female , Gene Expression Regulation/physiology , In Vitro Techniques , Male , Melatonin/biosynthesis , Pineal Gland/drug effects , Pineal Gland/metabolism , Pituitary Gland/drug effects , Pituitary Gland/metabolism , RNA, Messenger/metabolism
5.
Biochem J ; 330 ( Pt 1): 573-9, 1998 Feb 15.
Article in English | MEDLINE | ID: mdl-9461558

ABSTRACT

The growth-arrest genes (gas and gadd) are widely expressed during mammalian embryogenesis and may be useful as markers of nutritional stress in the embryo. F9 embryonal carcinoma cells have been used to characterize the effect of serum or amino acid deficiency on growth-arrest gene expression in a differentiating embryonic cell. The differentiation markers, homeobox B2 (HoxB2), collagen type IV and laminin B2, were not induced by growth arrest. Treatment with all-trans retinoic acid (RA) produced a dose-dependent increase in alkaline phosphatase activity, which was unchanged in lysine-deficient medium and reduced in low-serum medium. Low-serum medium also reduced HoxB2 expression. There was a transient 2-6-fold increase in mRNAs for C/EBP-beta, gadd153/CHOP-10 and gas5 genes 24 h after transfer to amino-acid-deficient media. The mRNAs for the gas2 and gas6 genes began to rise slowly by 5-10-fold after a delay of approx. 24 h. The transient increases did not occur in low-serum medium where there was a much smaller and slower increase. Differentiation caused 1-2-fold increases in gas2, gas3 and gas6 mRNA levels. The transient overexpression of gas5, gadd153/CHOP-10 and CCAAT-enhancer-binding protein-beta, and the later expression of gas6 mRNAs in response to amino acid deficiency, were not affected by differentiation. RA treatment increased the expression of gas3 and caused gas2 to be transiently overexpressed in amino-acid-deficient medium. Differentiation in serum-deficient medium did not significantly alter the levels of the growth-arrest gene mRNAs. These results show that in F9 cells the growth-arrest genes are expressed sequentially as a result of nutrient stress.


Subject(s)
CCAAT-Enhancer-Binding Proteins , Cell Division , Gene Expression Regulation, Developmental , Gene Expression Regulation, Neoplastic , Intercellular Signaling Peptides and Proteins , Membrane Proteins/genetics , Nutritional Physiological Phenomena , RNA, Small Nucleolar , Amino Acids/metabolism , Animals , Biomarkers , Cell Aggregation , Cell Differentiation , Culture Media , DNA-Binding Proteins/genetics , Mice , Microfilament Proteins/genetics , Proteins/genetics , Transcription Factor CHOP , Transcription Factors/genetics , Tretinoin/pharmacology
6.
Mol Reprod Dev ; 48(3): 310-6, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9322241

ABSTRACT

The gas and gadd family of genes, known collectively as the growth arrest genes, are associated with the negative control of mammalian cell growth. The steady-state levels of their mRNAs are increased by three to fivefold when exponentially multiplying cells are exposed to a variety of stresses including inadequate nutrition or the removal of serum. Reverse transcription-polymerase chain reaction (RT-PCR) has been used to analyze growth arrest gene expression in the preimplantation mouse embryo. The gas5, gas6, and CHOP-10 (gadd153, Ddit3) genes were expressed from the eight-cell stage onward. The gas2 and gas3 genes associated with apoptosis were not expressed. Embryos were cultured in kSOM medium and a semiquantitative RT-PCR method was used to measure the relative gene expression using beta-actin mRNA as a reference. The ratio of gas5 to beta-actin mRNA was high at the eight-cell stage and fell three to fivefold during development. The decline in the gas5:beta-actin ratio corresponded to the activation of true cell growth (cytokinesis). The gas6:beta-actin ratio was low at the eight-cell stage and increased by twofold as the blastocyst formed. CHOP-10 was expressed at a constant level throughout development. Embryos that had developed in vivo were compared with the equivalent blastocyst-stage embryos cultured in kSOM medium. There were no significant differences in the ratio of CHOP-10, gas5, or gas6 mRNAs relative to beta-actin. These results suggest that these genes are expressed as part of normal early embryonic development. The potential roles of the growth arrest genes are discussed.


Subject(s)
Blastocyst/metabolism , CCAAT-Enhancer-Binding Proteins , DNA-Binding Proteins/biosynthesis , Intercellular Signaling Peptides and Proteins , Nuclear Proteins/biosynthesis , Protein Biosynthesis , Transcription Factors/biosynthesis , 3T3 Cells , Actins/biosynthesis , Animals , Blastocyst/cytology , DNA-Binding Proteins/genetics , Gene Expression , Mice , Mice, Inbred C57BL , Nuclear Proteins/genetics , Polymerase Chain Reaction , Proteins/genetics , RNA/analysis , Transcription Factor CHOP , Transcription Factors/genetics , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL